Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. [electronic resource]
- Biochimica et biophysica acta Oct 2013
- 4860-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0006-3002
10.1016/j.bbagen.2013.06.029 doi
Amyloidogenic Proteins--metabolism Humans Oxidative Stress Protein Folding Proteostasis Deficiencies--metabolism